GSK's CEO Witty wants U.K. focus on manufacturing

GlaxoSmithKline ($GSK) CEO Andrew Witty (photo) said the U.K. needs to positively rebalance its economy, while growing the private sector with a focus on manufacturing, according to Social Enterprise. But trust in the private sector has eroded, he said, and business leaders have to lead by example in terms of corporate responsibility. Article

Suggested Articles

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.

Branded drug sales in China could suffer in the short term as marketing activities for new meds are limited to reduce the risk of contagion.

Korean CDMO Samsung Biologics is expanding and China API maker WuXi STA opened a 30,000-square-foot oligonucleotide manufacturing facility.